Athlete’s heart
21. In athlete’s heart, which echocardiographic feature is most commonly observed?
A. Increased left ventricular cavity size
B. Decreased ejection fraction
C. Right ventricular hypokinesia
D. Thickened mitral valve leaflets
22. Which of the following is typically absent in athlete’s heart but present in pathological hypertrophy?
A. Diastolic dysfunction
B. Mild LV wall thickening
C. Resting bradycardia
D. Increased stroke volume
23. A key differentiating test between athlete’s heart and cardiomyopathy is:
A. Deconditioning with repeat imaging
B. Chest X-ray
C. Serum troponin level
D. 24-hour urine protein
24. Athlete’s heart typically shows which pattern on ECG?
A. Sinus bradycardia and voltage criteria for LVH
B. Prolonged QT interval
C. Frequent ventricular ectopy
D. Delta wave
25. Which of the following supports a diagnosis of athlete’s heart over hypertrophic cardiomyopathy?
A. Symmetric wall thickening with normal diastolic function
B. Family history of sudden cardiac death
C. Asymmetric septal hypertrophy
D. Presence of late gadolinium enhancement on MRI
20-Point Summary Table: Athlete’s Heart
🔢 No. | 📘 Topic | Athlete’s heart🧠 Key Point |
---|---|---|
1️⃣ | Definition | Athlete’s heart is a benign, adaptive increase in cardiac size and function due to long-term endurance or strength training. |
2️⃣ | Cause | Physiological remodeling from regular intensive aerobic or anaerobic exercise. |
3️⃣ | Types of Training | Endurance (e.g., running) → volume overload; Strength (e.g., weightlifting) → pressure overload. |
4️⃣ | LV Cavity | Dilated in endurance athletes; concentric hypertrophy in strength athletes. |
5️⃣ | LV Wall Thickness | Mildly increased, but usually ≤13 mm. |
6️⃣ | RV Changes | Right ventricular enlargement may occur, often proportional to LV changes. |
7️⃣ | Resting Heart Rate | Often bradycardia (<60 bpm) due to high vagal tone. |
8️⃣ | ECG Findings | Sinus bradycardia, 1st-degree AV block, early repolarization, voltage criteria for LVH. |
9️⃣ | VO₂ Max | Increased significantly due to better cardiac output and peripheral efficiency. |
🔟 | Stroke Volume | Increased both at rest and during exercise. |
1️⃣1️⃣ | Diastolic Function | Normal or enhanced; helps differentiate from pathological hypertrophy. |
1️⃣2️⃣ | LA Enlargement | Mild left atrial enlargement may be seen due to increased preload. |
1️⃣3️⃣ | Ejection Fraction (EF) | Normal or mildly reduced at rest, but increases with exercise. |
1️⃣4️⃣ | NT-proBNP/Troponin | May be mildly elevated post-exercise but returns to normal—distinguishes from pathology. |
1️⃣5️⃣ | Reversibility | Changes regress within 3–6 months of detraining. |
1️⃣6️⃣ | Differentiation from HCM | No family history, symmetric hypertrophy, normal diastolic function, regression with detraining. |
1️⃣7️⃣ | Symptoms | Usually asymptomatic; no exertional syncope, angina, or breathlessness. |
1️⃣8️⃣ | Echocardiography Role | Key tool to differentiate from cardiomyopathy—assesses wall thickness, cavity size, function. |
1️⃣9️⃣ | MRI Findings | Normal tissue characteristics, no fibrosis or LGE (Late Gadolinium Enhancement). |
2️⃣0️⃣ | Prognosis | Excellent; associated with reduced cardiovascular risk and improved longevity. |
Athlete’s Heart vs Hypertrophic Cardiomyopathy (HCM) — Comparison Table
🔢 No. | 🔍 Feature | 🏃♂️ Athlete’s Heart | ❌ Hypertrophic Cardiomyopathy (HCM) |
---|---|---|---|
1️⃣ | Etiology | Physiological adaptation to training | Genetic disorder (AD; MYH7, MYBPC3 mutations) |
2️⃣ | LV Wall Thickness | Mild increase (usually ≤13 mm) | Often >15 mm (especially septal) |
3️⃣ | Pattern of Hypertrophy | Symmetrical | Asymmetrical (septal > posterior wall) |
4️⃣ | LV Cavity Size | Normal or increased | Normal or decreased |
5️⃣ | Diastolic Function | Normal or enhanced | Often impaired |
6️⃣ | Systolic Function | Normal EF, ↑ during exercise | Normal or hyperdynamic EF, ↓ with obstruction |
7️⃣ | Regression with Detraining | Yes (within months) | No regression |
8️⃣ | ECG Findings | Bradycardia, voltage criteria for LVH, early repolarization | LVH, T-wave inversion, Q waves, arrhythmias |
9️⃣ | Family History | Negative | Positive in ~60% |
🔟 | Symptoms | Asymptomatic | May have syncope, angina, palpitations, dyspnea |
1️⃣1️⃣ | Risk of Sudden Cardiac Death (SCD) | Very low | High, especially in young athletes |
1️⃣2️⃣ | Fibrosis on Cardiac MRI | Absent | Often present (Late Gadolinium Enhancement) |
1️⃣3️⃣ | NT-proBNP / Troponin Levels | Mild transient rise post-exercise | May be persistently elevated |
1️⃣4️⃣ | LA Size | Mildly enlarged | Often enlarged |
1️⃣5️⃣ | LVOT Obstruction | Absent | May be present (dynamic) |
1️⃣6️⃣ | Response to Exercise | Normal or supernormal | Limited by obstruction or arrhythmia |
1️⃣7️⃣ | Genetic Testing | Not indicated | Useful for diagnosis and family screening |
1️⃣8️⃣ | Tissue Doppler Imaging | Normal E’ velocity | ↓ E’ velocity (diastolic dysfunction) |
1️⃣9️⃣ | Management | Reassurance, monitor if unclear | Lifestyle restriction, beta-blockers, ICD if needed |
2️⃣0️⃣ | Prognosis | Excellent, improves fitness and longevity | Risk of SCD; lifelong monitoring needed |
